Literature DB >> 10708688

Permanent cerebral hypoperfusion: 'preconditioning-like' effects on rat energy metabolism towards acute systemic hypotension.

K Plaschke1, M A Weigand, A Michel, E Martin, H J Bardenheuer.   

Abstract

Chronic cerebrovascular disorders are often complicated by additional temporary ischaemic insults, resulting in substantial deterioration of brain energy metabolism. In the present study, chronic limitations of oxygen supply were induced in Wistar rats by 2 weeks of permanent bilateral common carotid artery occlusion (2-vo) to initiate a 'preconditioning-like' effect that protects rat brain energy metabolism against further acute systemic hypotension (15 min). Haemodynamic parameters, arterial blood gases and body temperature were monitored. Energy metabolites were determined in rat parietotemporal cerebral cortex: adenosine 5'-triphosphate (ATP), adenosine 5'-diphosphate (ADP), adenosine 5'-monophosphate (AMP), phosphocreatine (PCr), and adenosine by the high-pressure liquid chromatography (HPLC) technique and lactate spectrophotometrically. After 2 weeks, permanent 2-vo led to a significant decrease in the concentrations of cortical tissue ATP and PCr, from 3.06+/-0.48 to 2. 09+/-0.28 and from 4.27+/-0.63 to 3.35+/-0.41 micromol/g, respectively. These changes were associated with a two-fold increase in AMP and adenosine. Acute systemic hypotension alone (non-preconditioning) reduced ATP and PCr drastically, to 0.97+/-0. 51 and 1.76+/-1.23 micromol/g. Tissue concentrations of lactate, AMP, and adenosine were markedly increased, three- to five-fold, in 'non-preconditioned' brain tissue. In contrast, after 2 weeks of 2-vo acute hypotension did not significantly alter the cortical energy state any further. The effects of preconditioning on tissue ATP and PCr were most pronounced at 5 min and 48 h after reperfusion. In conclusion, permanent 2-vo seems to activate compensatory mechanisms, which effectively protect the rat's cortical energy metabolism against an additional ischaemic attack ('preconditioning-like' effect).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708688     DOI: 10.1016/s0006-8993(00)01950-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Neuromodulatory effect of propentofylline on rat brain under acute and long-term hypoperfusion.

Authors:  K Plaschke; M Grant; M A Weigand; J Züchner; E Martin; H J Bardenheuer
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  CT Permeability Imaging Predicts Clinical Outcomes in Acute Ischemic Stroke Patients Treated with Intra-arterial Thrombolytic Therapy.

Authors:  Nan Liu; Hui Chen; Bing Wu; Ying Li; Max Wintermark; Alan Jackson; Jun Hu; Yongwei Zhang; Zihua Su; Guangming Zhu; Weiwei Zhang
Journal:  Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.590

3.  A mouse model of cerebral oligemia: relation to brain histopathology, cerebral blood flow, and energy state.

Authors:  Konstanze Plaschke; Clemens Sommer; Helmut Schroeck; Dejana Matejic; Marika Kiessling; Eike Martin; Markus A Weigand; Hubert J Bardenheuer
Journal:  Exp Brain Res       Date:  2004-12-07       Impact factor: 1.972

4.  Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors.

Authors:  Anna Maria Pugliese; Serena Latini; Renato Corradetti; Felicita Pedata
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

5.  Chronic hypoperfusion alters the content and structure of proteins and lipids of rat brain homogenates: a Fourier transform infrared spectroscopy study.

Authors:  Neslihan Toyran; Faruk Zorlu; Gizem Dönmez; Kamil Oğe; Feride Severcan
Journal:  Eur Biophys J       Date:  2004-03-16       Impact factor: 1.733

Review 6.  The role of inflammasomes in vascular cognitive impairment.

Authors:  Luting Poh; Wei Liang Sim; Dong-Gyu Jo; Quynh Nhu Dinh; Grant R Drummond; Christopher G Sobey; Christopher Li-Hsian Chen; Mitchell K P Lai; David Y Fann; Thiruma V Arumugam
Journal:  Mol Neurodegener       Date:  2022-01-09       Impact factor: 14.195

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.